In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

C. Üstün, M. Beksac, K. Dalva, H. Koc, N. Konuk, O. Ilhan, M. Özcan, P. Topcuoglu, D. Sertkaya, M. Hayran

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences